The global artificial kidney market is anticipated to grow at a considerable CAGR of 13.0% during the forecast period. The artificial kidney is a device that is designed to mimic the functions of a real kidney. It is intended to support patients to fight with end-stage renal disease (ESRD) which requires continuous dialysis treatment to manage their condition. The market for artificial kidneys is driven by several factors, including the increasing prevalence of CKD and the rising demand for portable and user-friendly dialysis devices. The artificial kidney has the potential to revolutionize the dialysis industry by offering patients greater mobility and flexibility while undergoing dialysis treatment. For instance, according to the American Kidney Fund, in 2021 37 million Americans have kidney disease, nearly 810,000 Americans are living with kidney failure, 570,000 Americans are on dialysis, and 240,000 Americans are living with a kidney transplant.
Browse the full report description of “Artificial Kidney Market Size, Share & Trends Analysis Report by Device Type (Werable Artificial Kidney and Implantable Artificial Kidney), by Dialysis Type (Hemodialysis and Peritoneal Dialysis), and by End-User (Dialysis Centers, Specialty Clinics, and Hospitals) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/artificial-kidney-market
Moreover, the increasing number of diabetic patients globally, coupled with the funding provided by regulatory bodies further boosts the market growth. The International Diabetes Federation estimates that 537 million people were living with diabetes in 2021, with an expected increase to 784 million by 2045. As the prevalence of diabetes has increased, the prevalence of kidney disease has grown proportionally. Furthermore, in January 2023, the US government announced a funding of $25 million for KidneyX, to accelerate innovation in the prevention, diagnosis, and treatment of kidney disease. With this funding, the company developed a broad range of solutions, from patient-generated products that improve quality of life, such as clothing designed for the comfort and convenience of receiving dialysis, to technology that serves as the backbone of next-generation therapies for people with kidney failure, such as implantable filtration cartridges which are clot resistant and easier to transport than current home therapies. In addition, in February 2023, NextKidney secures $ 11.9 million in a Series B round, to develop a portable artificial kidney device. With this funding, NextKidney enhances the quality of life for dialysis patients through the development of the Neokidney home hemodialysis device and offers a solution that is both effective and convenient.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Device Type
o By Dialysis Type
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including B. Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nikkiso Co. Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Artificial Kidney Market Report Segment
By Device Type
By Dialysis Type
By End-User
Global Artificial Kidney Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/artificial-kidney-market